InTrack Investment Management Inc reduced its stake in Simulations Plus, Inc. (NASDAQ:SLP – Free Report) by 14.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 28,565 shares of the technology company’s stock after selling 4,978 shares during the period. InTrack Investment Management Inc owned 0.14% of Simulations Plus worth $822,000 at the end of the most recent quarter.
Several other large investors also recently modified their holdings of the stock. Envestnet Asset Management Inc. increased its position in Simulations Plus by 1.5% during the 2nd quarter. Envestnet Asset Management Inc. now owns 54,813 shares of the technology company’s stock worth $2,665,000 after buying an additional 784 shares during the period. Dimensional Fund Advisors LP raised its stake in Simulations Plus by 10.1% in the 2nd quarter. Dimensional Fund Advisors LP now owns 414,005 shares of the technology company’s stock worth $20,128,000 after purchasing an additional 37,992 shares in the last quarter. Public Sector Pension Investment Board boosted its holdings in Simulations Plus by 6.4% in the 2nd quarter. Public Sector Pension Investment Board now owns 35,227 shares of the technology company’s stock valued at $1,713,000 after purchasing an additional 2,122 shares during the period. Deerfield Management Company L.P. Series C acquired a new position in shares of Simulations Plus during the 2nd quarter worth approximately $811,000. Finally, The Manufacturers Life Insurance Company increased its holdings in shares of Simulations Plus by 7.7% during the second quarter. The Manufacturers Life Insurance Company now owns 6,391 shares of the technology company’s stock worth $311,000 after purchasing an additional 456 shares during the period. 78.08% of the stock is owned by institutional investors.
Analyst Ratings Changes
SLP has been the subject of several recent research reports. BTIG Research cut their price target on Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a research note on Thursday, October 24th. William Blair reiterated an “outperform” rating on shares of Simulations Plus in a research report on Wednesday, January 8th. KeyCorp decreased their price target on Simulations Plus from $40.00 to $35.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 8th. StockNews.com downgraded shares of Simulations Plus from a “hold” rating to a “sell” rating in a research note on Monday, November 4th. Finally, Stephens began coverage on shares of Simulations Plus in a research report on Friday, November 15th. They issued an “overweight” rating and a $39.00 target price for the company. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Simulations Plus presently has a consensus rating of “Moderate Buy” and a consensus price target of $49.00.
Insider Buying and Selling at Simulations Plus
In other news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $31.76, for a total transaction of $635,200.00. Following the transaction, the director now owns 3,442,584 shares in the company, valued at approximately $109,336,467.84. The trade was a 0.58 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 19.40% of the company’s stock.
Simulations Plus Trading Up 0.3 %
SLP opened at $29.92 on Friday. The company has a market cap of $601.09 million, a P/E ratio of 74.80 and a beta of 0.80. The company’s 50 day moving average is $29.80 and its 200-day moving average is $33.19. Simulations Plus, Inc. has a 1-year low of $24.00 and a 1-year high of $51.22.
Simulations Plus (NASDAQ:SLP – Get Free Report) last posted its earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The firm had revenue of $18.70 million for the quarter, compared to analysts’ expectations of $19.73 million. During the same quarter in the previous year, the firm posted $0.18 earnings per share. The company’s revenue was up 19.9% on a year-over-year basis. On average, equities analysts forecast that Simulations Plus, Inc. will post 1.09 EPS for the current year.
Simulations Plus Company Profile
Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.
Recommended Stories
- Five stocks we like better than Simulations Plus
- What is the Dow Jones Industrial Average (DJIA)?
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- Trading Stocks: RSI and Why it’s Useful
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- Investing in Travel Stocks Benefits
- MarketBeat Week in Review – 01/13 – 01/17
Want to see what other hedge funds are holding SLP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Simulations Plus, Inc. (NASDAQ:SLP – Free Report).
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.